Name: UMIN ID:
Unique ID issued by UMIN | UMIN000001347 |
---|---|
Receipt number | R000001636 |
Scientific Title | A clinical phase I study to define recommended dose of cyclophosphamide in combination with bortezomib and dexamethasone(C-BD) for relapsed and refractory multiple myeloma |
Date of disclosure of the study information | 2008/09/01 |
Last modified on | 2013/04/02 22:28:11 |
No. | Disposal | Last modified on | Item of update | |
---|---|---|---|---|
1 | Insert | 2008/09/01 13:42:44 | ||
2 | Update | 2008/09/01 19:53:08 | Recruitment status |
|
3 | Update | 2008/09/01 19:55:55 | Public title Acronym |
|
4 | Update | 2010/03/05 09:28:48 | Key inclusion criteria |
|
5 | Update | 2011/03/01 09:46:59 | Name of person sending information Organization Division name Address |
|
6 | Update | 2011/03/01 09:50:52 | Recruitment status Last follow-up date |
|
7 | Update | 2013/04/02 22:28:11 | Recruitment status Date of closure to data entry |